Breadcrumb Home News Are Pfizer's Covid pills going to highest-risk patients? Inside the U.S. rollout Are Pfizer's Covid pills going to highest-risk patients? Inside the U.S. rollout February 5, 2022 JP Leider, PhD comments on equity guardrails when resources are scarce. Previous News Christopher Wong Michaelson, PhD, Has Been Named the Koch Endowed Chair for Business Ethics at the University of St. Thomas Daniel Groll, PhD, Has Been Selected As One of the Mellon Periclean Faculty Leaders in the Humanities Rachel R. Hardeman, PhD, MPH, Joins the Hastings Center Board of Directors
